The Current Ratio as of December 2025 (TTM) for BridgeBio Oncology Therapeutics Inc. (BBOT) is 13.33

According to BridgeBio Oncology Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 13.33. This represents a change of 80.04% compared to the average of 7.40 of the last 4 quarters.

BridgeBio Oncology Therapeutics Inc. (BBOT) Historical Current Ratio (quarterly & annually)

How has BBOT Current Ratio performed in the past?

The mean historical Current Ratio of BridgeBio Oncology Therapeutics Inc. over the last ten years is 2.60. The current 13.33 Current Ratio has changed 51.18% with respect to the historical average. Over the past ten years (40 quarters), BBOT's Current Ratio was at its highest in in the March 2024 quarter at 90.42. The Current Ratio was at its lowest in in the December 2022 quarter at 0.

BridgeBio Oncology Therapeutics Inc. (BBOT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BridgeBio Oncology Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BridgeBio Oncology Therapeutics Inc. (BBOT) Average Current Ratio

How has BBOT Current Ratio performed in the past?

The current Current Ratio of BridgeBio Oncology Therapeutics Inc. (BBOT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BridgeBio Oncology Therapeutics Inc. (BBOT) Current Ratio vs. Peers

How is BBOT’s Current Ratio compared to its peers?

BridgeBio Oncology Therapeutics Inc.’s Current Ratio is greater than Mind Medicine (MindMed) Inc. (3.30), greater than UroGen Pharma Ltd. (4.14), greater than Nurix Therapeutics, Inc. (5.35), greater than Xencor, Inc. (5.34), greater than Kodiak Sciences Inc. (1.78), greater than AnaptysBio, Inc. (8.68), greater than Phathom Pharmaceuticals, Inc. (2.23), greater than Oculis Holding AG (4.55), greater than Tango Therapeutics, Inc. (4.75), greater than Septerna, Inc. (6.53),

Build a custom stock screener for BridgeBio Oncology Therapeutics Inc. (BBOT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BridgeBio Oncology Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BridgeBio Oncology Therapeutics Inc. (BBOT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BridgeBio Oncology Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.